Agonist efficacy at the β(2)AR is driven by the faster association rate of the G(s) protein.

Harwood CR, Sykes DA, Redfern-Nichols T, Underwood O, Nicholson C, Khoshgrudi AN, Koers EJ, Ladds G, Briddon SJ, Veprintsev DB

Open source

DOI: 10.3389/fphar.2025.1367991
Published: 2025
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1367991,
  title = {Agonist efficacy at the β(2)AR is driven by the faster association rate of the G(s) protein.},
  author = {Harwood CR and Sykes DA and Redfern-Nichols T and Underwood O and Nicholson C and Khoshgrudi AN and Koers EJ and Ladds G and Briddon SJ and Veprintsev DB},
  year = {2025},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2025.1367991},
  url = {https://doi.org/10.3389/fphar.2025.1367991}
}

RIS

TY  - JOUR
TI  - Agonist efficacy at the β(2)AR is driven by the faster association rate of the G(s) protein.
AU  - Harwood CR
AU  - Sykes DA
AU  - Redfern-Nichols T
AU  - Underwood O
AU  - Nicholson C
AU  - Khoshgrudi AN
AU  - Koers EJ
AU  - Ladds G
AU  - Briddon SJ
AU  - Veprintsev DB
PY  - 2025
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2025.1367991
UR  - https://doi.org/10.3389/fphar.2025.1367991
ER  -

APA

CR, H., DA, S., T, R., O, U., C, N., AN, K., EJ, K., G, L., SJ, B., & DB, V. (2025). Agonist efficacy at the β(2)AR is driven by the faster association rate of the G(s) protein.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2025.1367991

Source records

pubmed · retrieved 2026-09-25T14:04:18.811Z